There are 2789 resources available
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display
971P - Is there a clinical benefit of nivolumab + ipilimumab in patients older than 75 years with advanced solid tumors?
Presenter: Thierry Landre
Session: ePoster Display
973P - A phase II study of PDR001 among patients with recurrent and/or metastatic esophageal squamous cell carcinoma: An interim analysis of KM-12
Presenter: Dong Ki Lee
Session: ePoster Display
807P - Multi-centre study of escalated etoposide/cisplatin (Esc-EP) as a novel salvage regimen in advanced/refractory gestational trophoblastic neoplasia
Presenter: James Clark
Session: ePoster Display
808P - Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study
Presenter: Shin Nishio
Session: ePoster Display
809P - Comprehensive characterization of molecular features distinguishing uterine leiomyoma from leiomyosarcomas
Presenter: Xudong Liu
Session: ePoster Display
810P - Hormonal receptors in uterine leiomyosarcomas: How far is a primary tumor from multiple metastases?
Presenter: Élia Cipriano
Session: ePoster Display
811P - The stem cell markers expression in the primary ovarian cancer tissue
Presenter: Sneghanna Gening
Session: ePoster Display
812P - Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting
Presenter: Craig Knott
Session: ePoster Display
813P - Efficacy and safety of trastuzumab deruxtecan in HER2-expressing uterine carcinosarcoma (STATICE trial, NCCH1615): A multicenter, phase II clinical trial
Presenter: Kosei Hasegawa
Session: ePoster Display